三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
BTKi及BCL2i经治的后线CLL/SLL临床数据(非头对头对比):BGB-16673初步展现治疗优势
BTKi及BCL2i经治的后线CLL/SLL临床数据(非头对头对比):BGB-16673初步展现治疗优势
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:771KB
图片尺寸:2346*1451
同报告图片
/
4
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
fCDlgqzljJbliYIgICAgICAgfCDml7bpl7QgICAgICAgfAp8LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IENESzTmipHliLbliYIgICB8IDIwMjVIMSAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IEI3LUg0IEFEQyAgICB8IDIwMjVIMSAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjYgICAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IEI3LUgzIEFEQyAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IFBSTVQ1K01BVDJBICB8IDIwMjYgICAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjYgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45ryU56S65p2Q5paZ77yM5Zu96YeR6K+B5Yi456CU56m25omA
fCDntKLmiZjlhYvmi4kgIHwgIFIvUiBNQ0wgMiB8IDIwMjVIMiB8CnwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18LS0tLS0tLS0tfAp8IEJUSyBDREFDIHwgMUwgRVNDQyAgICAgfCAyMDI1SDEgIHwKfCDmm7/pm7fliKnnj6DljZXmipcgfCAxTCBHQyAzICAgICB8IDIwMjVIMiAgfAp8ICvmm7/pm7fliKnnj6DljZXmipcgfCBIRVJJWk9OLTMwMSAxTCBIRVIyK0dFQSAzIOacn+aVsOaNruivu+WHuiB8IDIwMjVIMiAgfAp8IOWhlOaLieWmpeWNleaKlyB8ICAgICAgICAgICAgIHwgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmvJTnpLrmnZDmlpnvvIzlm73ph5Hor4HliLjnoJTnqbbmiYA=
所属报告:
百济神州(6160.HK)-港股公司研究报告:龙头Biopharma高举高打商业化和研发迎收获期-250805(31页).pdf
打包全文图表
相关数据
BGB-43395的剂量爬坡和优化临床设计以及安全性数据
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
收藏
行业数据
2025-08-08
原图定位
查看详情
R/RCLL最新PFS数据支持BGB-16673开展与匹妥布替尼的头对头试验
fCDpobnnm64gfCBCR0ItMTY2NzMgfCDljLnlronluIPmm7/lsLwgfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCBuICAgIHwgNjYgICAgICAgfCAxMTkgICAgICB8Cnwg5Lit5L2NUEZTLCDmnIggKDk1JSBDSSkgfCAyMi44ICgxNS42KSB8IDE0LjAgKDExLjItMTYuNikgfAp8IOS4reS9jemaj+iuv+aXtumXtCwg5pyIIHwgMTUuNiAgICAgIHwgMTkuNCAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
BGB-43395安全性数据
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
收藏
行业数据
2025-08-07
原图定位
查看详情
表11、BGB-16673与非共价BTK或其他BTKPROTAC在治疗R/RCLL/SLL的临床数据对比(非头
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
收藏
行业数据
2025-07-24
原图定位
查看详情
表7、BGB-43395与CDK4、CDK4/6抑制剂在治疗2L+ER+乳腺癌的临床数据对比(非头对头对比)
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
收藏
行业数据
2025-07-24
原图定位
查看详情
部分BTKi全球销售额(百万美元)
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
收藏
行业数据
2025-06-25
原图定位
查看详情
部分BTKi美国销售额(百万美元)
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
收藏
行业数据
2025-06-25
原图定位
查看详情
图20、BGB-45035针对IRAK4降解的临床前数据
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
收藏
行业数据
2025-05-23
原图定位
查看详情
BGB-16673有望成为潜在同类最佳降解剂
fCDml6LlvoDmsrvnlpfnur/mlbDkuK3kvY3mlbAgfCA0IHwgMyB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLXwtLS0tLS18CnwgQlRL5oqR5Yi25YmCK0JDTDLmipHliLbliYLmmrTpnLIgfCA2MyUgIHwgNTAlICB8Cnwg5Zug55a+55eF6L+b5bGV5a+86Ie05pei5b6AQlRL5oqR5Yi25YmC5rK755aX57uI5q2iIHwgODklICB8IDcxJSAgfA==
收藏
行业数据
2025-04-18
原图定位
查看详情
接受BGB-43395治疗后TK1活性变化(仅限乳腺癌)
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
收藏
行业数据
2025-04-18
原图定位
查看详情
美国初治和R/RCLL新患BTKi市场份额占比
fCDlubTku70gfCDpmL/lj6/mm7/lsLwgfCDkvIrluIPmm7/lsLwgfCAKfCAtLS0gfCAtLS0gfCAtLS0gfCAKfCAyMDIxIHwgNDAlIHwgNjAlIHwgCnwgMjAyMiB8IDUwJSB8IDMwJSB8IAp8IDIwMjMgfCA0NSUgfCAyMCUgfCAKfCAyMDI0IHwgNDAlIHwgMTAlIHw=
收藏
竞争格局
2025-04-18
原图定位
查看详情
图24.BGB-16673临床管线布局(截至2024年3季度)
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
收藏
行业数据
2025-03-06
原图定位
查看详情
5款BTKi国内外适应症布局
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
收藏
行业数据
2025-02-06
原图定位
查看详情
图表4全球获批上市第一二三代BTKi对比
fCDliIbnsbsgICAgICAgICB8IOS8iuW4g+abv+WwvCAgIHwg6Zi/5Y2h5pu/5bC8ICAgIHwg5rO95biD5pu/5bC8ICAgIHwg5pu/5ouJ6bKB5pu/5bC8ICAgICB8IOWlpeW4jOabv+WwvCAgICAgIHwg5ZCh5omY5biD5pu/5bC8ICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tfAp8IOS8geS4miAgICAgICAgIHwg5by655SfJuiJvuS8r+e7tCB8IEFaICAgICAgICAgIHwg55m+5rWO56We5beeICAgIHwg5bCP6YeO5Yi26I2vL+WQieWIqeW+tyB8IOivuuivmuWBpeWNjiAgICAgIHwg56S85p2lL1JlZHggUGhhcm1hIHwKfCDmtbflpJbkuIrluILml7bpl7QgfCAyMDEz5bm0MTHmnIggfCAyMDE35bm0MTDmnIggIHwgMjAxOeW5tDEx5pyIICB8IDIwMjDlubQz5pyI77yI5LuF5Zyo5pel5pys5LiK5biC77yJIHwg5rW35aSW5pyq6I635om5ICAgIHwgMjAyM+W5tDHmnIggICAgICAgIHwKfCDlm73lhoXkuIrluILml7bpl7QgfCAyMDE35bm0OOaciCAgfCAyMDIz5bm0M+aciCAgIHwgMjAyMOW5tDbmnIggICB8IOWbveWGheacquiOt+aJuSAgICAgfCAyMDIw5bm0MTLmnIggICAgfCAyMDIz5bm0MTDmnIjlm73lhoXnurPlhaXkvJjlhYjlrqHor4QgfAp8IOe7k+WQiOaWueW8jyAgICAgfCDlhbHku7fkuI3lj6/pgIYgfCDlhbHku7fkuI3lj6/pgIYgIHwg5YWx5Lu35LiN5Y+v6YCGICB8IOWFseS7t+S4jeWPr+mAhiAgICAgfCDlhbHku7fkuI3lj6/pgIYgICAgfCDpnZ7lhbHku7flj6/pgIYgICAgICAgfAp8IOmAieaLqeaApyAgICAgICB8IOS4reetiSAgICAgICB8IOmrmCAgICAgICAgICB8IOmrmCAgICAgICAgICB8IOmrmCAgICAgICAgICAgICB8IOmrmCAgICAgICAgICAgIHwg6auYICAgICAgICAgICAgICAgfAp8IElDNTAgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgICAgICB8ICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgQlRLICAgICAgICAgIHwgMC41bk0gICAgICB8IDMuMOKAkzUuMSBuTSAgfCAwLjNuTSAgICAgICB8IDYuOG5NICAgICAgICAgIHwgMS42bk0gICAgICAgICB8IDMuMTVuTSAgICAgICAgICAgfAp8IEJNWCAgICAgICAgICB8IDAuOG5NICAgICAgfCA0Nm5NICAgICAgICB8IC0gICAgICAgICAgIHwgNm5NICAgICAgICAgICAgfCAtICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICB8CnwgRUdGUiAgICAgICAgIHwgNS4zbk0gICAgICB8ID4xMDAwbk0gICAgIHwgMjFuTSAgICAgICAgfCA+MTAwMG5NICAgICAgICB8IC0gICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgIHwKfCBIRVIyICAgICAgICAgfCA5LjRuTSAgICAgIHwgPjEwMDBuTSAgICAgfCA2NjFuTSAgICAgICB8ID4xMDAwbk0gICAgICAgIHwgLSAgICAgICAgICAgICB8IC0gICAgICAgICAgICAgICAgfAp8IElUSyAgICAgICAgICB8IDQuOW5NICAgICAgfCA+MTAwMG5NICAgICB8IDUwbk0gICAgICAgIHwgPjEwMDBuTSAgICAgICAgfCAtICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICB8CnwgSkFLMyAgICAgICAgIHwgMzJuTSAgICAgICB8ID4xMDAwbk0gICAgIHwgPjEwMDBuTSAgICAgfCA+MTAwMG5NICAgICAgICB8IC0gICAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgIHwKfCBURUMgICAgICAgICAgfCAxMG5NICAgICAgIHwgMTI2bk0gICAgICAgfCA0NG5NICAgICAgICB8IDc3bk0gICAgICAgICAgIHwgLSAgICAgICAgICAgICB8IC0gICAgICAgICAgICAgICAgfAp8IOe7neWvueeUn+eJqeWIqeeUqOW6piB8IDwxMCUgICAgICAgfCAyNSUgICAgICAgICB8IDQ14oCTNTAlICAgICAgfCA4OSUgICAgICAgICAgICB8IH4yMOKAkzgwJSAgICAgICB8IDcw4oCTNzQlICAgICAgICAgICB8Cnwg5Y2K6KGw5pyfICAgICAgIHwgNOKAkzEzaCAgICAgIHwgMeKAkzJoICAgICAgICB8IDI04oCTNGggICAgICAgfCAxLjXigJM0aCAgICAgICAgIHwgfjIwaCAgICAgICAgICB8IDIw4oCTMzBoICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrjgIpCcnV0b24gVHlyb3NpbmUgS2luYXNlIEluaGliaXRvcnMgaW4gQi1DZWxsIE1hbGlnbmFuY2llczogVGhlaXIgVXNlIGFuZCBEaWZmZXJlbnRpYWwgRmVhdHVyZXPjgIvvvIzlubPlronor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2024-10-15
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
临床数据展现同类最优潜力,头对头 III 期临床彰显信心。BGB-16673 在既往接受过多线治疗的 R/R CLL 患者中观察到显著缓解,针对共价 BTKi+BCL2i 经治患者、共价 BT Ki+非共价 BTKi+BCL2i 经治患者的 ORR 分别达 90.5%、75%。在针对 R/R CLL 适应症的早期临床探索中,BGB-16673 在患者治疗线数更高、既往 BTKi 和 BCL2i 暴露更充分的患者群体中仍展现出相较新一代非共价BTKi匹妥布替尼更优的PFS缓解(非头对头对比)。目前公司已开启针对既往接受过共价 BTK 抑制剂治疗的 R/R CLL/SLL 患者的全球 III 期研究,头对头匹妥布替尼,预计将于 2025 年下半年完成首例患者入组。目前公司针对 BGB-16673 进行了广泛的临床开发,并计划注册申报多种适应症,有望于 2026 年在全球范围申报 CLL/SLL。
行业数据
原图定位
当前图表所属:
百济神州(6160.HK)-港股公司研究报告:龙头Biopharma高举高打商业化和研发迎收获期-250805(31页).pdf
全球NHL发病人数持续增长,其中DLBCL、FL、CLL/SLL、MZL发病率较高
血液瘤分型复杂,NHL(包括CLL/SLL亚型)为核心市场之一
2025年和2026年关键早期催化剂:实体瘤管线迎来密集概念验证
2025年和2026年关键后期催化剂:血液瘤产品组合迎来加速兑现
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》